Literature DB >> 30273656

Parallels between artificial reprogramming and the biogenesis of cancer stem cells: Involvement of lncRNAs.

Theodore P Rasmussen1.   

Abstract

Cellular identity is established and maintained by the interplay of cell type-specific transcription factors and epigenetic regulation of the genome. During development in vivo and differentiation in vitro, transitions from one cell type to the next are triggered by cell signaling events culminating in modifications of chromatin that render genes accessible or inaccessible to the transcriptional apparatus. In recent years it has become apparent that cellular identity is plastic, and technological reprogramming methods such as somatic cell nuclear transfer and induced pluripotency can yield reprogrammed cells that have been restored to a state of developmental potency. Long noncoding RNAs (lncRNAs) are untranslated functional RNA molecules that are intimately involved in the regulation of the chromatin of protein-coding genes. In fact, recent evidence shows that there are more lncRNA species in the cell than mRNA species and that most protein-coding genes are likely to be under epigenetic regulation mediated by lncRNAs. This review examines lncRNA function in reprogrammed pluripotent cells and cancer stem cells. Because cancer stem cells arise from normal cells, their biogenesis can be viewed as a reprogramming process that occurs in vivo, and parallels between artificial reprogramming and cancer stem cell biogenesis are discussed.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cancer stem cells; Epigenetics; Reprogramming; Stem cells; lncRNA

Mesh:

Substances:

Year:  2018        PMID: 30273656     DOI: 10.1016/j.semcancer.2018.09.009

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  5 in total

1.  LncRNA SPRY4-IT1 regulates breast cancer cell stemness through competitively binding miR-6882-3p with TCF7L2.

Authors:  Xinyue Song; Xiaoxue Zhang; Xinnan Wang; Lianze Chen; Longyang Jiang; Ang Zheng; Ming Zhang; Lin Zhao; Minjie Wei
Journal:  J Cell Mol Med       Date:  2019-11-17       Impact factor: 5.310

2.  Inhibiting proliferation and metastasis of osteosarcoma cells by downregulation of long non-coding RNA colon cancer-associated transcript 2 targeting microRNA-143.

Authors:  Fengjiang Bi; Can Chen; Jing Fu; Lei Yu; Jia Geng
Journal:  Oncol Lett       Date:  2021-02-08       Impact factor: 2.967

Review 3.  Propagation and Maintenance of Cancer Stem Cells: A Major Influence of the Long Non-Coding RNA H19.

Authors:  Clément Lecerf; Evodie Peperstraete; Xuefen Le Bourhis; Eric Adriaenssens
Journal:  Cells       Date:  2020-12-05       Impact factor: 6.600

Review 4.  Noncoding RNA Roles in Pharmacogenomic Responses to Aspirin: New Molecular Mechanisms for an Old Drug.

Authors:  Mohammad Amin Khazeei Tabari; Mohammad Amir Mishan; Mona Moradi; Mohanna Khandan; Hooman Khoshhal; Abdolkarim Mahrooz; Abouzar Bagheri
Journal:  Biomed Res Int       Date:  2021-12-09       Impact factor: 3.411

5.  UPF1 contributes to the maintenance of endometrial cancer stem cell phenotype by stabilizing LINC00963.

Authors:  Hao Chen; Jian Ma; Fanfei Kong; Ning Song; Cuicui Wang; Xiaoxin Ma
Journal:  Cell Death Dis       Date:  2022-03-22       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.